OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
CSX57

Cleanspace Holdings Ltd

Medical Equipment, Supplies & DistributionVerified

Cleanspace Holdings Ltd has a fully diluted share count of 78,949,593, with no additional shares outstanding in the diluted scenario, indicating no immediate dilution risk. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available for Cleanspace Holdings Ltd, and no industry-specific preferred metrics are provided for comparison. Analyst estimates suggest a modest improvement in earnings, with a mean EPS estimate of 0.01 AUD compared to a last actual EPS of -0.01 AUD. Revenue estimates also show a positive trend, with a mean revenue estimate of 23.1 million AUD versus actual revenue of 19.77 million AUD. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to assess revenue concentration or geographic diversification. The company's growth trajectory appears modest, with analyst estimates projecting a 16.9% increase in revenue from 19.77 million AUD to 23.1 million AUD. However, the absence of historical revenue data prevents a more detailed analysis of growth trends. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as the diluted share count is equal to the basic share count. Recent events and filings are not detailed in the available source documents, limiting the ability to assess recent corporate developments or strategic shifts.

30-day price · CSX(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyCleanspace Holdings Ltd
TickerCSX.AX
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
AI analysis

Business. Cleanspace Holdings Ltd provides medical equipment, supplies, and distribution services within the healthcare sector.

Classification. Cleanspace Holdings Ltd is classified under the industry "Medical Equipment, Supplies & Distribution" within the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Cleanspace Holdings Ltd has a fully diluted share count of 78,949,593, with no additional shares outstanding in the diluted scenario, indicating no immediate dilution risk. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability metrics are not available for Cleanspace Holdings Ltd, and no industry-specific preferred metrics are provided for comparison. Analyst estimates suggest a modest improvement in earnings, with a mean EPS estimate of 0.01 AUD compared to a last actual EPS of -0.01 AUD. Revenue estimates also show a positive trend, with a mean revenue estimate of 23.1 million AUD versus actual revenue of 19.77 million AUD. Segment and geographic exposure data are not disclosed in the available source documents, making it impossible to assess revenue concentration or geographic diversification. The company's growth trajectory appears modest, with analyst estimates projecting a 16.9% increase in revenue from 19.77 million AUD to 23.1 million AUD. However, the absence of historical revenue data prevents a more detailed analysis of growth trends. Risk factors include the inability to assess liquidity risk due to missing balance-sheet data and no going-concern language in source documents. Dilution risk is currently low, as the diluted share count is equal to the basic share count. Recent events and filings are not detailed in the available source documents, limiting the ability to assess recent corporate developments or strategic shifts.
Key takeaways
  • Cleanspace Holdings Ltd has no immediate dilution risk, as the diluted share count is equal to the basic share count.
  • Analyst estimates suggest a modest improvement in earnings and revenue for the company.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Revenue growth is projected at 16.9%, but historical data is not available for a more detailed analysis.
  • Segment and geographic exposure data are not disclosed, limiting visibility into revenue concentration and diversification.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$49.9M$16.0M$11.4M$10.8M
FY-3$13.4M-$15.1M-$11.3M-$10.9M
FY-2$12.1M-$11.8M-$8.1M-$7.1M
FY-1$15.7M-$4.8M-$3.1M-$2.2M
FY0$19.8M-$1.3M-$478.3k$339.6k
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$50.7M$40.7M
FY-3$38.4M$29.8M
FY-2$29.0M$22.0M
FY-1$26.1M$19.1M
FY0$27.6M$19.2M
PeriodOCFCapExFCFSBC
FY-4$13.5M-$1.7M$10.8M
FY-3-$13.0M-$605.8k-$10.9M
FY-2-$12.0M-$5.3k-$7.1M
FY-1-$1.7M-$30.1k-$2.2M
FY0$1.1M-$103.2k$339.6k
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Healthcare Services & Equipment · cohort 369 companies
MetricCSXActivity
Op margin3.9% medp25 -31.3% · p75 14.4%
Net margin2.4% medp25 -30.5% · p75 11.1%
Gross margin46.7% medp25 28.2% · p75 63.1%
R&D / revenue6.9% medp25 6.7% · p75 7.1%
CapEx / revenue-4.8% medp25 -11.6% · p75 -2.4%
Debt / equity17.9% medp25 2.7% · p75 52.2%
Observations
IR observations
Mean EPS estimate0.01 AUD
Last actual EPS-0.01 AUD
Mean revenue estimate23,100,000 AUD
Last actual revenue19,767,000 AUD
Mean EBIT estimate300,000.00 AUD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 06:13 UTC#b98d9ab0
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 17:20 UTCJob: f4952102